News Alert – Review the Patidegib 2% Topical Gel Clinical Trial Posting
Pellepharm’s Phase III Clinical Trial for Patidegib Topical Gel 2% just posted to ClinicalTrials.gov
Patient recruitment for Pellepharm’s Phase 3 Patidegeb Topical Gel 2% is not currently active since the site locations cannot be published until contracts are signed and official. The BCCNS Alliance is working directly with Pellepharm and the clinical sites to make certain eligible patients are connected to locations closest to their home. More information will be available as clinical trial sites are published or opened.
Click here if you meet the eligibility criteria and want more information about the trial and possible site locations.